HIGHLIGHTS
- who: Fengyuan Luo and collaborators from the School of Medical Information Engineering, Gannan Medical University, Ganzhou, China have published the paper: Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model, in the Journal: Diagnostics 2022, 12, x FOR PEER REVIEW of 12/Dec/2022
- what: The aim of this study was to construct an model for predicting overall survival in serous ovarian cancer. The above results further suggested that the prognostic biomarker developed in this study had a robust predictive ability. The authors did not compare the singlegene-based biomarkers and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.